ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed
Meifang Yu
Matched on ORCID iD 0000-0002-1878-307X; OpenAlex author ID A5024353326. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 38
2018: 1 paper · 2019: 2 papers · 2020: none · 2021: 2 papers · 2022: 1 paper
Papers 6
- Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment. Co-author DOI 10.1053/j.gastro.2022.02.024↗
- APOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasis. Co-author DOI 10.1038/s43018-021-00268-8↗
- Comparative Untargeted Metabolomic Profiling of Induced Mitochondrial Fusion in Pancreatic Cancer. First author DOI 10.3390/metabo11090627↗
- Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-18-1785↗
- Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. Co-author DOI 10.1172/jci.insight.126915↗
- Mitochondrial Fusion Suppresses Pancreatic Cancer Growth via Reduced Oxidative Metabolism Co-author DOI 10.2139/ssrn.3188491↗
Closest collaborators
The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Cullen M. Taniguchi · 6 shared papers, 2018–2022 · strength 0.57
- Paper Comparative Untargeted Metabolomic Profiling of Induced Mitochondrial Fusion in Pancreatic Cancer. DOI 10.3390/metabo11090627↗
- Paper Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment. DOI 10.1053/j.gastro.2022.02.024↗
- Paper APOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasis. DOI 10.1038/s43018-021-00268-8↗
- Anirban Maitra · 5 shared papers, 2018–2022 · strength 0.43
- Paper Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment. DOI 10.1053/j.gastro.2022.02.024↗
- Paper APOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasis. DOI 10.1038/s43018-021-00268-8↗
- Paper Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer. DOI 10.1158/0008-5472.can-18-1785↗
- Tara N. Fujimoto · 4 shared papers, 2018–2022 · strength 0.34
- Paper Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment. DOI 10.1053/j.gastro.2022.02.024↗
- Paper Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer. DOI 10.1158/0008-5472.can-18-1785↗
- Paper Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. DOI 10.1172/jci.insight.126915↗
- Daniel Lin · 4 shared papers, 2018–2022 · strength 0.34
- Paper Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment. DOI 10.1053/j.gastro.2022.02.024↗
- Paper Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer. DOI 10.1158/0008-5472.can-18-1785↗
- Paper Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. DOI 10.1172/jci.insight.126915↗
- Nicholas D. Nguyen · 3 shared papers, 2019–2022 · strength 0.33
- Paper Comparative Untargeted Metabolomic Profiling of Induced Mitochondrial Fusion in Pancreatic Cancer. DOI 10.3390/metabo11090627↗
- Paper Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment. DOI 10.1053/j.gastro.2022.02.024↗
- Paper Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. DOI 10.1172/jci.insight.126915↗
- Ya’an Kang · 3 shared papers, 2018–2021 · strength 0.24
- Paper APOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasis. DOI 10.1038/s43018-021-00268-8↗
- Paper Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. DOI 10.1172/jci.insight.126915↗
- Paper Mitochondrial Fusion Suppresses Pancreatic Cancer Growth via Reduced Oxidative Metabolism DOI 10.2139/ssrn.3188491↗
- Jason B. Fleming · 3 shared papers, 2018–2021 · strength 0.24
- Paper APOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasis. DOI 10.1038/s43018-021-00268-8↗
- Paper Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. DOI 10.1172/jci.insight.126915↗
- Paper Mitochondrial Fusion Suppresses Pancreatic Cancer Growth via Reduced Oxidative Metabolism DOI 10.2139/ssrn.3188491↗
- Sonal Gupta · 3 shared papers, 2018–2019 · strength 0.22
- Paper Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer. DOI 10.1158/0008-5472.can-18-1785↗
- Paper Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. DOI 10.1172/jci.insight.126915↗
- Paper Mitochondrial Fusion Suppresses Pancreatic Cancer Growth via Reduced Oxidative Metabolism DOI 10.2139/ssrn.3188491↗
- Eugene Jon Koay · 3 shared papers, 2018–2019 · strength 0.22
- Paper Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer. DOI 10.1158/0008-5472.can-18-1785↗
- Paper Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. DOI 10.1172/jci.insight.126915↗
- Paper Mitochondrial Fusion Suppresses Pancreatic Cancer Growth via Reduced Oxidative Metabolism DOI 10.2139/ssrn.3188491↗
- Joseph Abi Jaoude · 1 shared paper, 2021 · strength 0.13
- Abagail M. Delahoussaye · 1 shared paper, 2022 · strength 0.12
- Emily G. Caggiano · 1 shared paper, 2022 · strength 0.12
- Carolina J. García García · 1 shared paper, 2022 · strength 0.12
- Natividad Roberto Fuentes · 1 shared paper, 2022 · strength 0.12
- Maria E. Monberg · 1 shared paper, 2022 · strength 0.12
- Jaewon James Lee · 1 shared paper, 2022 · strength 0.12
- Jun Zhao · 1 shared paper, 2022 · strength 0.12
- Vincent Bernard · 1 shared paper, 2022 · strength 0.12
- Dieter Saur · 1 shared paper, 2022 · strength 0.12
- Melena D. Bellin · 1 shared paper, 2021 · strength 0.09
- Matthew H. G. Katz · 1 shared paper, 2021 · strength 0.09
- Sonja M. Wörmann · 1 shared paper, 2021 · strength 0.09
- Robert W. Cowan · 1 shared paper, 2021 · strength 0.09
- Ravikanth Maddipati · 1 shared paper, 2021 · strength 0.09
- Fredrik I. Thege · 1 shared paper, 2021 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.